• Using (R)-MG132 to Validate Proteasome Mechanisms

  2026-09-04

  (R)-MG132 is a functionally inactive MG-132 enantiomer designed to separate proteasome-dependent biology from solvent, uptake, and off-target effects. This workflow shows how to use it as a matched negative control in cervical cancer metabolism studies, biochemical assays, and mechanistic validation.

• Lypressin Acetate: Mechanism and Research Use

  2026-09-03

  Lypressin acetate, also called Lysine vasopressin acetate, is a lysine-substituted vasopressin peptide that activates V1a, V1b, and V2 receptors. Its established research relevance includes antidiuretic and vasoconstrictive models, while its proposed SARS-CoV-2 RdRp activity remains an emerging, evidence-limited application.

• Nintedanib in ATRX-Deficient Glioma Research

  2026-09-03

  Nintedanib (BIBF 1120) provides a practical way to interrogate coordinated VEGFR, FGFR, and PDGFR signaling in tumor and fibrosis models. This workflow combines ATRX-stratified glioma assays, TMZ combination testing, and disciplined DMSO handling to improve mechanistic resolution and reproducibility.

• PAD4-IN-2 TFA: Designing Better NET Assays

  2026-09-02

  PAD4-IN-2 TFA, also known as Compound 5i TFA, is a tumor-targeted PAD4 inhibitor that connects sialic-acid-directed uptake with suppression of H3 citrullination and NET biology. This guide focuses on assay design, mechanistic interpretation, and translational decision-making rather than repeating a conventional pathway overview.

• Clodronate Liposomes in Aging Macrophage Studies

  2026-09-02

  Clodronate Liposomes provide a powerful way to test whether macrophages causally shape age-related immune dysfunction. This article connects liposome-mediated depletion with new findings on phagocytosis, mitochondrial ROS, collagen, and assay interpretation.

• Palmitic acid: Protocol and QC Guidance

  2026-09-01

  Palmitic acid (SKU N2456) provides a characterized saturated long-chain fatty acid for metabolic disorder research, inflammation signaling studies, lipid metabolism pathway assays, and protein palmitoylation workflows. It is unsuitable for aqueous-only protocols and should be prepared in a compatible organic solvent for prompt use rather than long-term solution storage.

• S Tag Peptide: Workflow and QC Guide

  2026-08-31

  S Tag Peptide (SKU A6007) is a soluble 15-amino-acid sequence used as a genetically encoded S-peptide fusion tag for recombinant protein detection, antibody-based purification, and protein solubility improvement. It is best suited to aqueous workflows with compatible anti-S-Tag reagents and should not be used when ethanol solubility, long-term solution storage, or independent ribonuclease activity is required.

• Z-VEID-FMK: A Caspase-6 Inhibitor Workflow

  2026-08-31

  Z-VEID-FMK enables controlled, cell-permeable inhibition of caspase-6 in apoptosis, neuronal, and cancer models. This guide shows how to separate caspase-6-dependent apoptosis from the caspase-1-driven pyroptosis described in a recent lung cancer study, while improving assay design and troubleshooting.

• Tamsulosin Workflows for Urological Research

  2026-08-30

  Build reproducible Tamsulosin assays for α1A-adrenergic signaling, smooth muscle relaxation, ureteral stone models, and postoperative urinary retention research. The workflow also shows how the compound can serve as a mechanistic comparator when translating biomarker findings from prostate cancer studies without conflating receptor pharmacology with androgen-deprivation outcomes.

• EV Release Inhibition in Triple-Negative Breast Cancer

  2026-08-29

  McNamee et al. systematically evaluated pharmacological strategies for suppressing extracellular vesicle release from triple-negative breast cancer cells. The study’s key contribution was showing that multiple EV subpopulations appear to transmit aggressive traits, while residual vesicle release after partial inhibition can still affect recipient-cell behavior.

• Lypressin acetate: Practical Assay Workflows

  2026-08-29

  Lypressin acetate connects vasopressin-receptor pharmacology with practical antidiuretic, vasoconstriction, and exploratory antiviral workflows. This guide emphasizes assay design, quantified activity benchmarks, sample handling, and troubleshooting for more reproducible translational experiments.

• Allosteric Biosensor Tracks Endogenous Protein Dynamics

  2026-08-28

  The reference study introduces circStep, a circular RNA-based allosteric biosensor that converts recognition of a native protein into fluorescence from unlocked fluorogenic aptamers. By avoiding protein overexpression, genomic tagging, and direct modification of the protein of interest, the platform enables live-cell analysis of protein localization, abundance changes, and nucleocytoplasmic relocalization.

• Vasopressin Analogues: Mechanisms, Methods, and Uses

  2026-08-28

  Glavaš and colleagues present an integrated review of vasopressin biology, receptor pharmacology, peptide engineering, and clinical translation. Its central contribution is to show how natural and synthetic analogues can redistribute antidiuretic, vasoconstrictor, stability, and receptor-selectivity profiles, while also identifying emerging antiviral hypotheses that require stronger validation.

• Methylprednisolone in Translational Bone Models

  2026-08-27

  Methylprednisolone provides a controlled glucocorticoid challenge for connecting inflammatory signaling with skeletal injury. This workflow shows how to combine cytokine assays, osteoclast readouts, micro-CT, angiography, and histology to test protective interventions with greater translational confidence.

• Fulvestrant: ERα, MDM2, and Immune Assays

  2026-08-27

  Fulvestrant (ICI 182,780) is more than an ERα antagonist: it is a practical perturbation tool for separating receptor degradation, MDM2 regulation, and estrogen-dependent immune signaling. This guide connects breast cancer assays with a rigorously defined hemorrhagic-shock study while highlighting controls, formulation, and translational limits.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page